AC
RARX
Athanor Capital’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-224,786
| Closed | -$10.8M | – | 585 |
|
|
2020
Q1 | $10.8M | Buy |
224,786
+170,386
| +313% | +$8.18M | 0.7% | 39 |
|
|
2019
Q4 | $2.55M | Buy |
54,400
+31,400
| +137% | +$1.47M | 0.12% | 81 |
|
|
2019
Q3 | $544K | Buy |
23,000
+9,400
| +69% | +$222K | 0.04% | 134 |
|
|
2019
Q2 | $409K | Buy |
+13,600
| New | +$409K | 0.05% | 92 |
|
|
2018
Q2 | – | Sell |
-67,150
| Closed | -$357K | – | 79 |
|
|
2018
Q1 | $357K | Buy |
+67,150
| New | +$357K | 0.17% | 61 |
|